Eli Lilly & Co. Aktie

Hims & Hers Health (NYSE: HIMS) stock labored mightily on Wednesday, but in the end, it couldnt top the benchmark

Hims & Hers Health shares rose 5% Tuesday after announcing it will offer Eli Lilly’s Zepbound and Mounjaro through its

(HealthDay News) — The telehealth company Hims & Hers Health is expanding its weight-loss offerings by adding new medications to

Primary care company knownwell said on Wednesday it will provide health and weight-management services on Eli Lillys direct-to-consumer online healthcare

Hims & Hers investors are clearly antsy about where the company’s weight-loss business is going and Tuesday’s announcement was supposed

Eli Lilly (NYSE: LLY) is the most valuable healthcare company in the world, worth more than $700 billion. Over the

Shares of Hims & Hers Health (NYSE: HIMS) surged on Tuesday, closing the session up 5.25% after having been up

Telehealth firm Hims & Hers Health NYSE:HIMS said on Tuesday it plans to sell Eli Lillys NYSE:LLY weight-loss drug, as

Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lillys weight-loss drug, as it widens